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Abstract
Background: It is uncertain whether the association of the intraoperative driving pressure (ΔP) with postoperative
pulmonary complications (PPCs) depends on the surgical approach during abdominal surgery. Our primary
objective was to determine and compare the association of time–weighted average ΔP (ΔPTW) with PPCs. We also
tested the association of ΔPTW with intraoperative adverse events.
Methods: Posthoc retrospective propensity score–weighted cohort analysis of patients undergoing open or closed
abdominal surgery in the ‘Local ASsessment of Ventilatory management during General Anaesthesia for Surgery’ (LAS
VEGAS) study, that included patients in 146 hospitals across 29 countries. The primary endpoint was a composite of
PPCs. The secondary endpoint was a composite of intraoperative adverse events.
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Results: The analysis included 1128 and 906 patients undergoing open or closed abdominal surgery, respectively. The
PPC rate was 5%. ΔP was lower in open abdominal surgery patients, but ΔPTW was not different between groups. The
association of ΔPTW with PPCs was significant in both groups and had a higher risk ratio in closed compared to open
abdominal surgery patients (1.11 [95%CI 1.10 to 1.20], P < 0.001 versus 1.05 [95%CI 1.05 to 1.05], P < 0.001; risk
difference 0.05 [95%CI 0.04 to 0.06], P < 0.001). The association of ΔPTW with intraoperative adverse events was also
significant in both groups but had higher odds ratio in closed compared to open abdominal surgery patients (1.13
[95%CI 1.12– to 1.14], P < 0.001 versus 1.07 [95%CI 1.05 to 1.10], P < 0.001; risk difference 0.05 [95%CI 0.030.07],
P < 0.001).
Conclusions: ΔP is associated with PPC and intraoperative adverse events in abdominal surgery, both in open and
closed abdominal surgery.
Trial registration: LAS VEGAS was registered at clinicaltrials.gov (trial identifier NCT01601223).
Keywords: Pneumoperitoneum, Laparoscopy, Laparoscopic surgery, Perioperative ventilation, Protective ventilation,
PEEP, Respiratory mechanics, Driving pressure
Introduction
The incidence of postoperative pulmonary complications
(PPCs) is high and depends on the used definitions and
the studied population [1]. Their occurrence is associated
with increased morbidity and mortality [2, 3]. PPCs can be
prevented by reducing lung strain by using a low tidal vol-
ume (VT) [4], ,and by using sufficient positive end–expira-
tory pressure (PEEP) [5]. Since the driving pressure (ΔP),
defined as the difference between plateau pressure and
PEEP, is associated with the development of PPCs [5, 6],
titrating VT and PEEP to obtain the lowest ΔP could be an
effective preventive strategy against PPCs.
The overall behaviour of the respiratory system de-
pends on the properties of its components, i.e., the artifi-
cial and native airways, and the lung tissue, but also the
chest wall consisting of the rib cage and diaphragm.
Most of the force applied during invasive ventilation is
needed to expand the chest wall, and only a lesser
amount to inflate lung tissue [7]. When the chest wall
elastance increases, e.g., during pneumoperitoneum, the
ΔP increases, even when VT is left unchanged [8]. This
rise in ΔP is often interpreted as ‘innocent’, and there-
fore accepted during intraoperative pneumoperitoneum.
However, the cephalad shift of the diaphragm could in-
duce, or worsen atelectases during intraoperative ventila-
tion, and the resulting increase in ΔP is related with a
rise in lung applied force [9]. In other words, it should
be questioned if a rise in ΔP during pneumoperitoneum
with closed abdominal surgery can be accepted.
To determine and compare the independent associa-
tions of ΔP with PPCs in patients undergoing open ab-
dominal surgery versus patients undergoing closed
abdominal surgery, we reassessed the database of the
‘Local ASsessment of Ventilatory management during
General Anaesthesia for Surgery’ (LAS VEGAS) study
[10]. The LAS VEGAS study was a large observational
study that included a large proportion of patients at an
increased risk for PPCs. The primary hypothesis tested
here was that the association of ΔP with PPCs is weaker
in closed versus open abdominal surgery patients. The
primary objective was to test the association of a time–
weighted average driving pressure (ΔPTW) with PPCs.
The secondary objective was to test the association of
ΔPTW with intraoperative adverse events.
Methods
Study design and setting
This is a posthoc analysis of the LAS VEGAS study [10],
carried out following current guidelines and the recom-
mendations of the statement for strengthening the
reporting of observational studies in epidemiology
(STROBE) (www.strobe-statemenent.org). The statistical
analysis plan was predefined, updated, and finalised be-
fore data extraction, and is presented as Additional file 1.
The LAS VEGAS study is a worldwide international
multicentre prospective seven–day observational study
describing intraoperative ventilation practice, complica-
tions during anaesthesia, PPCs in the first five postoper-
ative days, hospital length of stay, and hospital mortality.
The ethical committee of the Academic Medical Cen-
ter, Amsterdam, the Netherlands, approved the LAS
VEGAS study protocol (W12_190#12.17.0227). Each
participating centre obtained approval from their institu-
tional review board if needed, and patients were in-
cluded after obtaining written informed consent when
dictated by national or regional legislation. The LAS
VEGAS study was partially funded and endorsed by the
European Society of Anaesthesiology and registered at
clinicaltrials.gov (study identifier NCT01601223, first
posted date: 17/05/2012).
Inclusion and exclusion criteria
The LAS VEGAS study recruited consecutive patients
undergoing general anaesthesia with mechanical
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ventilation during anaesthesia for surgery during a
seven–days timeframe between 14 January and 4 March
2013. Exclusion criteria of the LAS VEGAS study were:
(1) age < 18 years, (2) having received mechanical ventila-
tion in the preceding month, (3) obstetric or ambulatory
surgical interventions, and (4) cardiothoracic surgery
cardiopulmonary bypass.
For the current analysis, inclusion was restricted to pa-
tients undergoing abdominal surgery. The following add-
itional exclusion criteria were used: (1) insufficient data
to calculate ΔP, i.e., on at least two timepoints sufficient
data had to be available to calculate the driving pressure
for a patient to be included; (2) to increase the homo-
geneity of the compared patient cohorts and avoid using
erroneous data, patients who received intraoperative
ventilation through an airway device other than an endo-
tracheal tube as well as patients under an assisted or
spontaneous ventilation mode were excluded; (3) pa-
tients in whom laparoscopy only assisted the surgery,
i.e., surgeries that could not be classified as mere open
or mere closed abdominal surgery, were also excluded
from the current analysis.
Data recording and calculations
Full details on data collection can be found in the ori-
ginal publication of the LAS VEAGS study [10], and in
Additional file 2. In the LAS VEGAS study database,
ventilatory parameters at every hour of surgery, from in-
duction up to the last hour of surgery, were recorded.
Data in the LAS VEGAS database was validated through
two rounds of extensive data cleaning to check for in-
valid or incomplete data. Local investigators were quer-
ied on incorrect or missing data and had to correct
those in the cleaning rounds.
The following calculations were performed. ΔP was
calculated by subtracting PEEP from plateau pressure or
inspiratory pressure at every hour in volume–controlled
and pressure–controlled ventilated patients, respectively.
ΔPTW, i.e., the pressure that is proportional to the
amount of time spent at each driving pressure in relation
to the total time, was calculated by summing the mean
values between consecutive time points multiplied by
the time between those points and then dividing by the
entire time [11]. Similarly, time–weighted average peak
pressure and PEEP were determined. Details on calcula-
tions are provided in the Additional file 2 Figure S1.
Definitions
PPCs were defined as a collapsed composite of the fol-
lowing events: unexpected postoperative invasive or
non–invasive ventilation, acute respiratory failure, acute
respiratory distress syndrome, pneumonia, and pneumo-
thorax. The occurrence of each type of complication was
monitored until hospital discharge but restricted to the
first five postoperative days.
Intraoperative adverse events were defined as an or-
dinal composite of the following events: any oxygen de-
saturation or lung recruitment manoeuvres performed
to rescue from hypoxemia, any need for adjusting venti-
lator settings for reducing airway pressures or correction
of expiratory flow limitation, any hypotension or need
for vasoactive drugs, and any new cardiac arrhythmia.
A detailed list of definitions of the composites of PPCs
and intraoperative adverse events is provided in Add-
itional file 2 Table S1 and Table S2.
Endpoints
The primary endpoint was the composite of PPCs. The
secondary endpoint was the composite of intraoperative
adverse events.
Analysis plan
The analysis plan was prespecified before data access,
and we used data of all available patients in the LAS
VEGAS database without formal sample size calculation.
Also, as the purpose of the analysis was exploring a
physiological hypothesis, we did not specify any a priori
effect size.
Continuous variables were reported as median and
interquartile ranges; categorical variables expressed as n
(%). Normality of distributions was assessed by inspect-
ing quantile–quantile plots. If variables were normally
distributed, the two–sample t–test was used; if not, the
Wilcoxon rank sum test was used. We used the Chi–
square test or Fisher’s exact test for categorical variables,
or when appropriate, as relative risks. Statistical uncer-
tainty was expressed by showing the 95%–confidence in-
tervals (CI). Since the simultaneous occurrence of
various intraoperative adverse events is frequent, we
analysed them as an ordinal variable with a range span-
ning from zero to seven adverse events.
To control for confounding effects, we estimated the
association of ΔPTW with PPC with a weighted mixed–
effect logistic regression, and the association of ΔPTW
with intraoperative adverse events with a weighted
mixed ordinal regression. To fit the models, we intro-
duced centres as a random intercept, and an inverse
probability weighting factor computed from the covari-
ate–balancing propensity score (CBPS) method to simul-
taneously optimise treatment assignment prediction, i.e.,
ΔPTW as a continuous variable, and confounders influ-
ence [12]. The CBPS procedure sets mean independence
between treatment, i.e., ΔPTW, and covariates to ensure
covariate balancing and estimates the propensity score
with the generalised method of moments method. For
both outcomes, we fitted the model for each of the com-
pared patient cohorts respectively, i.e., patients who
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underwent open surgery intervention and those who
underwent closed surgical intervention. We used a Wald
z-test to test the difference between odds ratios from
models fitted on closed and open surgery cohort.
Models’ goodness of fit was assessed by residual diagno-
sis based on scaled quantile residuals (R DHARMa pack-
age v. 0.2.4) and simulated residuals (R sure package v
0.2.0) for logistic and ordinal models, respectively.
To build the CBPS to relate exposure variable, i.e.,
ΔPTW, with potential confounders, we included by clin-
ical judgment the Assess Respiratory Risk in Surgical Pa-
tients in Catalonia (ARISCAT) risk class [13, 14], and
the average intraoperative VT. Then we performed fea-
ture selection with an augmented backward elimination
selection method introducing 37 preoperative and intra-
operative variables (Additional file 2:Statistics for a de-
tailed list). The selection was based on a sequential
process where initially all variables entered the model
and finally those preoperative and intraoperative factors
that yielded a change in the effect estimate > 0.1 and a
significance criterion (alpha) < 0.1 were included. The
algorithm stopped when all variables left in the model
complied with both criteria [15]. We carried out a selec-
tion process of potential variables to avoid bias in the ef-
fect estimates using a comprehensive strategy to prevent
the drawbacks of simple stepwise methods [16]. The
model’s internal validation was assessed by bootstrap
using 5 hundred generated samples and estimating the
Area Under Curve (AUC) of the full and stepwise–se-
lected variables models.
To further unravel the effect of the surgical approach on
PPCs, we performed a sensitivity analysis fitting a mixed
logistic regression with a random intercept for centre on a
propensity score matched cohort. The propensity score
was used to match patients with a similar covariable struc-
ture using the R matchit package carrying out the match-
ing with the nearest neighbour method with a caliper of
0.1 with a ratio of patients in the open surgery arm of 2 to
1. Full details on the covariables introduced in the propen-
sity score matching procedure can be found in the Add-
itional file 2: Statistics. To assess the type of surgery as an
effect modifier, we carried out another sensibility analysis
fitting a weighted mixed logistic regression model on all
data, i.e., both surgery cohorts, introducing the type of
surgery as an independent variable and an interaction
term between ΔPTW and type of surgery.
Statistical significance was considered for two–tailed
P < 0.05. No imputation routine of missing values and
no correction for multiple comparisons was prespecified;
thus, all the findings should be viewed as exploratory.
All analyses were performed with R 3.5.2 (The R Foun-
dation for Statistical Computing, www.r-project.org).
Additional explanation on the used methods can be
found in the Additional file 2: Statistics.
Results
Patients
Of a total of 3265 patients undergoing abdominal sur-
gery in the LAS VEGAS study, 1231 had insufficient data
for calculating the ΔP (37.7%).
Out of the remaining 2034 patients, 1218 (60%) pa-
tients underwent an open abdominal intervention, and
906 (40%) patients, a closed abdominal surgical proced-
ure (Fig. 1). ΔP could be calculated on two different
timepoints in 34.4 and 53.7% of patients in the open and
closed surgery group, respectively (Fig. 2 and Table S3).
In 87% of patients, ΔP could be calculated on up to four
timepoints.
Baseline demographic data, surgery–related and intra-
operative ventilation characteristics are presented in Ta-
bles 1 and 2, and Fig. 2. Open abdominal surgery patients
had higher ASA class and ARISCAT risk score, lower
functional status, and fewer elective procedures, longer
surgery times, less neuromuscular reversals, and received
more intraoperative transfusions and fluids. Lower abdo-
men surgeries were the most frequently performed in the
open abdominal surgery patients, while upper abdomen
interventions were performed more often in closed ab-
dominal surgery patients. ΔPTW was not different between
the open and closed surgery groups (Table 2).
Primary and secondary outcome rates
In 102 (5%) patients, one or more PPC occurred, with a
higher prevalence in open surgery patients than in patients
who underwent a closed surgical procedure (7 versus 3%;
P < 0.001). Hypotension, or need for vasopressors was
more frequently observed during open surgery, while the
need for airway pressure reduction was more often needed
during closed surgery (Table 3).
Propensity score estimation variables
The variables that finally entered the propensity score
and covariate balance assessment are detailed in the
Additional file 2: Statistics and Fig. S2 and S3.
Association of ΔPTW with PPCs
ΔPTW was significantly associated with PPCs in both sur-
gical groups. The association was stronger in closed ab-
dominal surgery patients (odds ratio (OR), 1.17 [95%CI
1.16 to 1.19]; P < 0.001; risk ratio (RR), 1.11 [95%CI 1.10
to 1.20], P < 0.001) than in patients who underwent an
open abdominal surgical intervention (OR, 1.07 [95%CI
1.06 to 1.08]; P < 0.001; RR 1.05 [95% CI 1.05 to 1.05]),
with a significant difference (difference between ORs: 0.09
[95%CI 0.07 to 0.10]; P < 0.001; risk difference 0.05:
[95%CI 0.04 to 0,06]), P < 0.001. Residuals plots are re-
ported in Additional file 2: Figure S4.
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Association of ΔPTW with the occurrence of adverse
events
ΔPTW was significantly associated with intraoperative adverse
events in both open and closed surgery patients. Also, here
the association was stronger in closed surgery patients (1.13
[95%CI 1.12 to 1.14]) than in patients who underwent an
open abdominal intervention (1.07 [95%CI 1.05 to 1.10]), dif-
ference between ORs 0.05 [95%CI 0.03 to 0.07]; P < 0.001.
Sensitivity analyses
ΔPTW was significantly associated with PPCs (OR, 1.08
[95%CI 1.06 to 1.09], P < 0.001) with closed surgery
patients having a lower probability of occurrence (OR,
0.14 [95%CI 0.12 to 0.16, P < 0.001) with a significant
interaction between ΔPTW and closed surgery (OR, 1.09
[95%CI 1.08 to 1.11], P < 0.001). The marginal effect of
ΔPTW by type of surgery on PPCs probability is showed
in Fig. 3. A rise in ΔPTW was associated with an in-
creased probability of PPCs in both surgery types, with a
steeper increase in closed surgery patients for ΔPTW
above 20 cmH2O ∙ hour
− 1.
After matching, the resulting cohort consisted of 344
open surgery patients and 254 closed surgery patients.
Baseline characteristics between groups were well
Fig. 1 Patients’ inclusion flowchart
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balanced (Additional file 2: Table S4 and S5). Type of
surgery at matched levels of driving pressure was not
associated with either outcome. (Additional file 2: Table
S5 and S6).
Discussion
The main findings of this posthoc analysis of the LAS
VEGAS study can be summarised as follows: (i.) the
intraoperative ΔPTW was not different between open
and closed surgery groups; (ii.) ΔPTW was associated
with PPCs in both closed and open surgery patients; (iii.)
ΔPTW was associated with intraoperative adverse events
in both closed and open surgery patients; and (iv.) the
type of surgery had a modifying effect on the association
between ΔPTW and PPCs, with an increasing probability
of PPCs at high ΔPTW in closed surgery. The last
Fig. 2 Mechanical ventilation settings over time. Green: open surgery, Orange: closed surgery. Hour 0 h represents the induction of general anaesthesia. Solid
lines are means, and bandwidths is 95% bootstrapped confidence intervals. Gray boxes: More than 95% of data points represented
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Age, years 54 [40 to 67] 49 [36 to 64] 58 [45 to 69] < 0.001 9 [6 to 21]
Gender, male (%) 42% (846/2034) 34% (306/906) 48% (540/1128) < 0.001 14% [9 to 18%]
Ethnicity, % (n/N) 0.194
Caucasian 88% (1787/2.030) 87% (786/902) 89% (1001/1.128)
Black 1% (20/2.030) 1% (6/902) 1% (14/1.128)
Asian 3% (58/2.030) 4% (33/902) 2% (25/1.128)
Other 8% (165/2.030) 8% (77/902) 8% (88/1.128)
BMI (Kg∙m−2) 26.2 [23.3 to 30.0] 26.7 [23.6 to 31.3] 25.8 [22.9 to 29.3] < 0.001 0.8 [0.04 to 1.6]
Weight (kg) 75.0 [65.0 to 87.0] 77.0 [68.0 to 93.0] 74.0 [64.0 to 85.0] 0.001 3 [8 to 13]
PBW (kg) 60.6 [55.1 to 69.0] 59.7 [54.2 to 67.8] 61.5 [56.0 to 69.7] < 0.001 1.82 [1.8 to 2]
ASA class, % (n/N) < 0.001
1 24% (495/2.028) 31% (276/904) 20% (219/1.124)
2 49% (989/2.028) 53% (477/904) 46% (512/1.124)
3 24% (488/2.028) 16% (146/904) 30% (342/1.124)
4 3% (53/2.028) 1% (5/904) 4% (48/1.124)
5 0% (3/2.028) 0% (0/904) 0% (3/1.124)
ARISCAT score 26 [18 to 38] 18 [15 to 31] 34 [18 to 41] < 0.001 16 [16 to 16]
ARISCAT class, % (n/N) < 0.001
< 26 51% (985/1.945) 68% (607/888) 36% (378/1.057)
26–44 38% (741/1.945) 26% (231/888) 48% (510/1.057)
> 44 11% (219/1.945) 6% (50/888) 16% (169/1.057)
Preop. SpO2,% 98 [96 to 99] 98 [96 to 99] 97 [96 to 99] 0.004 0 [0 to 3]
Current smoker, % 20% (413/2.034) 21% (79/906) 20% (222/1.128) 0.468 2% [3 to 7%]
Chronic comorbidity, % (n/N)
Metastatic cancer 7% (138/2.034) 2% (22/906) 10% (116/1.128) < 0.001 8% [5 to 9%]
Chronic kidney failure 4% (81/2.034) 1% (13/906) 6% (68/1.128) < 0.001 5% [2 to 6%]
COPD 7% (138/2.034) 7.% (83/906) 6% (55/1.128) 0.290 1% [1 to 3%]
Heart failure 7% (143/2.034) 6% (53/906) 8% (90/1.128) 0.075 2% [1 to 4%]
OSAS 2% (42/2.034) 3% (27/906) 1% (15/1.128) 0.015 2% [1 to 3%]
Neuromuscular diseasea 1% (17/2.034) 1% (6/906) 1% (11/1.128) 0.599 0.3% [0.3 to 1%]
Liver dysfunction 1% (29/2.034) 1% (5/906) 2% (24/1.128) 0.210 1% [1 to 2%]
Functional Status, % (n/N) < 0.001
Independent 92% (1872/2.034) 96% (867/906) 89% (1005/1.128)
Partially dependent 7% (135/2.034) 4% (32/906) 9% (103/1.128)
Totally dependent 1% (27/2.034) 1% (7/906) 2% (20/1.128)
Preop. resp. infection,% (n/N) 5% (95/2.034) 4% (35/906) 5% (60/1.128) 0.150 2% [0.5 to 3%]
Preop. Hb (g∙dl−1), % (n/N) 13.4 [12.2 to 14.0] 13.5 12.6 to 14.5] 13.3 [11.9 to 14.5] < 0.001 0.2 [0.3 to 1]
Preop. anemia (Hb ≤ 10 g dl−1) 9% (1738/1.846) 3% (21/798) 8% (87/1.048) < 0.001 5% [3 to 7%]
Preop. creatinine (g∙dl− 1) 0.8 [0.7 to 1.0] 0.8 [0.7 to 1.0] 0.9 [0.7 to 1.1] < 0.001 0.04 [0.01 to 0.1]
Preop transfusion, % (n/N) 1% (23/2.034) 0% (3/906) 2% (20/1.128) 0.004 1% [0.5 to 1%]
Surgical procedureb, % (n/N)
Lower GI 26% (286/1.098) 14% (124/906) 31% (346/1.128) < 0.001 17% [13 to 20%]
Upper GI, HBP 28% (303/1.098) 47% (429/906) 20% (222/1.128) < 0.001 27% [23 to 31%]
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Vascular surgery 2% (25/1.098) 0% (0/906) 3% (30/1.128) < 0.001 2% [1 to 3%]
Aortic surgery 2% (19/1.098) 0% (0/906) 2% (20/1.128) < 0.001 1% [1 to 2%]
Urological 19% (204/1.098) 9% (81/906) 14% (162/1.128) < 0.001 5% [2 to 8%]
Gynaecological 18% (195/1.098) 26% (233/906) 17% (188/1.128) < 0.001 9% [6 to 12%]
Endocrine surgery 1% (9/1.098) 1% (5/906) 1% (10/1.128) 0.443 0.3% [0.5 to 1%]
Transplant 2% (18/1.098) 0% (0/906) 2% (20/1.128) < 0.001 2% [1 to 3%]
Neurosurgery 5% (52/1.098) 0% (1/906) 10% (109/1.128) < 0.001 9% [8 to 11%]
Other procedure 3% (30/1.098) 5% (43/906) 19% (214/1.128) < 0.001 14% [11 to 17%]
Urgency of Surgeryc, % (n/N) < 0.001
Elective 84% (1705/2.034) 87% (792/906) 81% (913/1.128)
Urgent 12% (235/2.034) 9% (85/906) 13% (150/1.128)
Emergency 4% (94/2.034) 4% (29/906) 6% (65/1.128)
Duration of surgeryd, min 86 [55 to 149] 70 [50 to 110] 105 [65 to 172] < 0.001 35 [21 to 43]
Duration of anaesthesiae, min 115 [80 to 190] 100 [71 to 147] 140 [91 to 205] < 0.001 40 [20 to 60]
Time of surgery, % (n/N) < 0.843 0.2 [0.2 to 1]
Daytimef 95% (1925/2034) 95% (859/906) 95%(1066/1128)
Night–time 5% (109/2034) 5% (47/906) 5% (962/1128)
Antibiotic prophylaxis, % (n/N) 80% (1.628/2.034) 73% (662/906) 84% (956/1.127) 0.005 11% [8 to 15%]
Mean arterial pressure, mmHg 82 [74 to 92] 84 [76 to 94] 80 [72 to 90] < 0.001 4 [4 to 7]
Heart rate, beats∙min 72 [63 to 82] 73 [64 to 82] 72 [62 to 83] 0.276 1 [3 to 11]
Intraop. procedures, % (n/N)
Epidural anesthesia 12% (237/2.034) 3% (25/906) 19% (212/1128) < 0.001 16% [13 to 18%]
Opioid < 0.001
Short–acting 18% (367/2.015) 22% (193/900) 16% (174/1.115)
Long–acting 70% (1410/2.015) 62% (561/900) 76% (849/1.115)
Both 12% (238/2.015) 16% (146/900) 8% (92/1.115)
Neuromuscular Blockade 97% (1965/2.028) 97% (876/903) 97% (1089/1.125) 0.887 0.2% [0.1 to 1%]
Neuromuscular Monitoring 23% (474/2.032) 25% (230/906) 22% (244/1.126) 0.055 3% [0 to 7%]
Neuromuscular Reversal 41% (827/2.024) 49% (437/901) 35% (390/1.123) < 0.001 14% [9 to 18%]
TIVA 10% (211/2.027) 11% (102/902) 10% (109/1.125) 0.266 1% [1 to 4%]
Transfusion 6% (113/2.034) 1% (13/906) 9% (100/1.128) < 0.001 7% [6 to 9%]
Total Fluids (mL∙ kg−1) 18 [12 to 30] 15 [13 to 30] 23 [14 to 26] < 0.001 8 [6 to 10]
Crystalloids (mL∙ kg−1) 17 [12 to 26] 14 [11 to 21] 20 [13 to 31] < 0.001 5 [4 to 7]
Colloids (mL∙ kg−1) 7 [3 to 9] 4 [0 to 7] 7 [6 to 12] < 0.001 3 [2 to 6]
Data are presented as median [25th–75th percentile] or % (n/N). For binary and continuous variables risk difference and median difference with 95% confidence
intervals in square brackets are reported respectively
Abbreviations: BMI Body mass index, ASA American Society of Anaesthesiologists, ARISCAT Assess Respiratory Risk in Surgical Patients in Catalonia risk index,14,15
Hb Haemoglobin, GI Gastrointestinal, HBP Hepatobiliopancreatic, SpO2 Peripheral oxygen saturation, CI Confidence interval, COPD Chronic Obstructive Pulmonary
Disease, OSAS Obstructive sleep apnea sydnrome, TIVA Total Intravenous Anaesthesia
aNeuromuscular disease affecting the respiratory system
bThe same patient may have more than one surgical indication
cUrgency of surgery is defined as elective: surgery that is scheduled in advance because it does not involve a medical emergency, urgent: surgery required within
< 48 h, emergent: surgery performed when the patients’ life or well being are threatened
dDuration of surgery is the time between skin incision and closure of the incision
eDuration of anaesthesia is the time between start of induction and tracheal extubation or discharge from operation room if the mechanical ventilation
is continued
fDaytime surgery is defined as anaesthesia induction between 8:00 a.m. and 19:59 p.m.
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finding, though, was not confirmed in the matched co-
hort analysis.
This analysis uses the database of a worldwide inter-
national multicentre prospective observational study as a
convenience sample [10], strictly followed a plan, and
was characterised by a robust method accounting for the
multilevel data structure and allowing precise estimation
and confounder control, even with seven or fewer events
per confounder [17, 18]. Also, the outcome of interest,
i.e., PPCs, was predefined, well–described, and largely
followed the European Perioperative Clinical Outcome
(EPCO) group definitions [19]. Furthermore, the study
population was defined to minimise information and se-
lection bias and to have a sufficient number of patients
while keeping an acceptable number of timepoints at
which ΔPTW could be calculated per patient.
A recent metanalysis of individual trials on protective
ventilation during general anaesthesia for cardiac or
thoracic surgery found a significant association between
ΔPTW and PPCs (OR 1.16, 95% CI 1.13 to 1.19;










Ventilation mode, % (n/N) 0.013 Pressure–controlled
4% [1 to 8%]
Volume–controlled 77% (1571/2034) 79% (895/906) 75% (676/1128)
Pressure–controlled 23% (463/2034) 21% (233/906) 25% (230/1128)
Tidal Volume
Absolute (ml) 505 [465 to 570] 504 [462 to 570] 505 [465 to 572] 0.567 1 [24 to 25]
Per PBW (ml∙kg− 1) 8.0 [7.0 to 9.0] 8.5 [7.6 to 9.5] 8.2 [7.4 to 9.2] 0.001 0.2 [0.07 to 0.5]
Per ABW (ml∙kg− 1) 7.0 [6.0 to 8.0] 6.8 [5.8 to 7.7] 7.0 [6.1 to 7.9] < 0.001 0.2 [0.1 to 0.4]
Minute ventilation (L∙kg− 1) 6.0 [6.0 to 7.0] 6.5 [5.8 to 7.2] 6.3 [5.5 to 7.0] < 0.001 0.2 [0.1 to 0.4]
Respiratory system compliance
Dynamic, ml∙cm∙H2O
−1 26 [21 to 32] 25 [20 to 32] 27 [21 to 33] < 0.001 2 [0 to 4]
Static, ml∙cm∙H2O
−1 42 [35 to 50] 41 [33 to 50] 43 [36 to 51] < 0.001 1 [0.4 to 2]
Routine recruitment maneuvers, % (n/N) 12% (238/2.029) 13% (119/905) 11% (119/1.124) 0.087 2% [1 to 5%]
FiO2, % 50 [45 to 56] 54 [48 to 70] 50 [45 to 63] < 0.001 4 [4 to 10]
SpO2, % 99 [98 to 100] 99 [98 to 100] 99 [98 to 100] < 0.001 0 [0 to 0]
a




−1) 8 [6 to 11] 8 [6 to 11] 8 [6 to 10] 0.091 0.2 [0.09 to 1.2]
Maximum value (cmH2O) 14 [11 to 18] 16 [12 to 20] 14 [11 to 17] < 0.001 2 [2 to 7]
Minimum value (cmH2O) 11 [9 to 14] 11 [9 to 15] 11 [9 to 14] 0.008 0 [0 to 17]
Coefficient of variation (%) 10 [5 to 20] 15 [6 to 26] 9 [4 to 15] < 0.001 5 [4 to 8]
Peak pressure
Time–weighted average (cmH2O∙hour
−1) 12 [9 to 15] 11 [9 to 15] 12 [9 to 15] 0.414 0.2 [0.1 to 1.1]
Highest value (cmH2O) 20 [17 to 24] 21 [18 to 26] 19 [16 to 23] < 0.001 2 [2 to 10]
Lowest value (cmH2O) 16 [14 to 20] 17 [14. to 20] 16 [14 to 20] 0.011 1 [1 to 3]
Coefficient of variation (%) 8 [4 to 15] 11 [5 to 19] 7 [3 to 12] < 0.001 5 [3 to 6]
PEEP
Time–weighted average (cmH2O∙hour
−1) 2 [1 to 3] 2 [1 to 4] 2 [1 to 3] 0.019 0 [0 to 0]
Highest value (cmH2O) 5 [2 to 5] 5 [2 to 5] 5 [2 to 5] 0.255 0 [0 to 0]
Lowest value (cmH2O) 4 [0 to 5] 4 [0 to 5] 3 [0 to 5] 0.186 1 [1 to 5]
Coefficient of variation (%) 0 [0 to 22] 0 [0 to 22] 0 [0 to 22] 0.579 0 [0 to 0]
Data are presented as median [25th–75th percentile] or % (n/N). For binary and continuous variables risk difference and median difference with confidence
intervals are reported respectively. Abbreviations: EtCO2 End-tidal CO2, FiO2 Fraction of inspired oxygen, SpO2 Peripheral oxygen saturation, OR Odds ratio
aDifference between groups is significant but very small and masked by rounding process
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p < 0·0001) [5]. We found an almost identical associ-
ation in patients undergoing closed abdominal surgery.
Thus, our results confirm that ΔPTW is a promising tar-
get for interventions to prevent PPCs after closed ab-
dominal surgery. The sensitivity analysis showed that the
association between ΔPTW and PPCs was lower in pa-
tients who underwent a closed surgical procedure. How-
ever, this was not confirmed in the propensity score
matched analysis, probably because of smaller sample
size due to the matching procedure.
ΔP is an indicator of the amount of strain delivered to
the respiratory system during mechanical ventilation [7].
Several studies investigated the effect of pneumoperito-
neum on respiratory mechanics. Pneumoperitoneum
was consistently found to decrease chest wall compli-
ance, whereas lung compliance seems mostly spared by
it [20–27]. Thus, inferring the amount of lung strain
from plateau pressure and PEEP during pneumoperito-
neum is challenging, since the part of the rise in plateau
pressure caused by chest wall stiffening should not be
regarded as a rise in lung strain [28]. Consequently, a
higher ΔP during closed abdominal surgery is often seen
as innocent. The current analysis results reject this as-
sumption, as the association of ΔP with PPCs was stron-
ger in patients undergoing closed abdominal surgery
than in patients undergoing open abdominal surgery.
Pneumoperitoneum can affect lung mechanics in
several ways [20–27]. A cranial shift of the diaphragm
during laparoscopic surgery increases alveolar collapse,
especially in lung parts close to the diaphragm. This is
particularly true in upper abdominal surgery, which was
the most common surgical procedure in patients under-
going closed surgery in the here studied cohort [29, 30].
PEEP may partially prevent this, and usually only when
using high PEEP [31]. In the patients studied here,
mostly low PEEP was used, regardless of the group.
Additional studies are needed to test how high PEEP af-
fects the association between ΔP with PPCs during
pneumoperitoneum. Also, we found that ΔP was higher
in patients undergoing closed surgery than in patients
undergoing open abdominal surgery. However, open ab-
dominal surgery lasted longer, resulting in a comparable
ΔPTW in the two groups. The higher absolute ΔP was
compensated for by a shorter duration of intraoperative
ventilation, and vice versa. Using the ΔPTW allowed us
to estimate an exposure limit threshold to an injurious
factor as in occupational health. The steeper increase in
probability of PPCs above a 20 cm H2O∙hour
− 1 found in
the sensitivity analysis can be related to an increase in
collapsed lung tissue.
As expected, PPCs occurred more frequently in open
abdominal surgery patients. An increased baseline risk
could explain this due to typical differences in patient
characteristics and the duration and the type of surgery.
However, this finding strengthens the current analysis
since we observed the association even in a cohort of










Severe PPC (composite), % (n/N) 5% (102/2.034) 3% (28/906) 7% (74/1.128) 0.001
Intraoperative complications
Desaturation 4% (73/2.026) 3% (26/903) 4% (47/1.123) 0.148
Unplanned rescue maneuvers 4% (87/2.026) 4% (41/903) 4% (46/1.123) 0.704
Need for ventilatory pressure reduction 4% (77/2.025) 6% (57/903) 2% (20/1.102) < 0.001
Expiratory flow limitation 1% (14/2.015) 1% (12/898) 0% (2/1.117) 0.005
Hypotension 28% (562/2.027) 20% (182/903) 34% (380/1.124) < 0.001
Use of vasopressors 23% (469/2.027) 17% (153/903) 28% (316/1.122) < 0.001
New arrhythmia onset 1% (13/2.027) 0% (2/903) 1% (11/1.124) 0.065
Individual PCCs
Acute respiratory failure 3% (58/2.034) 2% (21/906) 3% (37/1.128) 0.245
Need for mechanical ventilation 2% (44/2.034) 1% (11/906) 3% (33/1.128) 0.013
Acute respiratory distress syndrome 0% (6/2.034) 0% (0/906) 0% (6/1.128) 0.074
Pneumonia 0% (16/2.034) 0% (2/906) 1% (14/1.128) 0.019
Pneumothorax 0% (4/2.034) 0% (0/906) 0% (4/1.128) 0.186
In–hospital mortality 1% (22/1.892) 0% (3/838) 2% (19/1.054) 0.007
Length of stay (days) 3 [1 to 5] 1 [0 to 3] 5 [2 to 8] < 0.001
Data are presented as median [25th–75th percentile] or % (n/N)
PPC Postoperative pulmonary complications
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patients, i.e., closed abdominal surgery, at low risk for
PPCs and even after controlling for confounding effects
with propensity score analysis.
Several intraoperative ventilation approaches, like the
use of recruitment manoeuvres and higher PEEP, may re-
sult in a lower ΔP [32, 33]. Findings of a metanalysis in-
cluding clinical trials on intraoperative ventilation suggest
that PEEP titrations that resulted in a ΔP rise increased
the risk of PPCs [5]. One randomised clinical trial showed
an intraoperative PEEP strategy targeting the best compli-
ance to reduce PPCs, though this was only a secondary
endpoint in that study [34]. Thus, the best approach to
minimise PPCs remains a matter of debate.
ΔPTW was associated with intraoperative adverse
events in both closed and open surgery patients. Among
all adverse events, airway pressure reduction was more
frequently needed in closed surgery group underlining
the need for ventilation strategies to lower peak and
plateau pressures in this group of patients reflecting
unacceptable high airway pressure during surgery.
Several limitations must be acknowledged. We used the
parent LAS VEGAS definition of PPCs. This definition dif-
fers from what was somewhat recently proposed [1], but
they remain reasonably comparable. The protocol of the
LAS VEGAS study did not include the collection of
oesophageal pressure recordings. Information regarding
surgical positioning was not collected, and intra–abdom-
inal pressure levels were also not recorded in the database
of the LAS VEGAS study. Both could influence ΔPTW,
though [35–37]. Due to the additional strict exclusion cri-
teria, we excluded a considerable number of patients.
Thus, the findings of this analysis need confirmation in
other studies. Also, some patients had only a few time-
points at which ΔP could be calculated. Furthermore, we
only included patients with an endotracheal tube and pa-
tients who received controlled ventilation, limiting our
focus on a specific type of intraoperative airway device
and ventilation mode. Of note, 25% of patients had a Body
Mass Index (BMI) > 30 kg∙m− 2. Extrapolating this analy-
sis’s findings to obese or morbidly obese patients should
be done with some caution. Also, the original LAS VEGA
S study was performed 7 years ago. Since then, there could
have been changes in clinical practice, e.g., in the use of
‘Enhanced Recovery After Surgery’ (ERAS) pathways and
muscle relaxant monitoring during and reversal at the end
of surgery. Although the time gap between research find-
ings and practice changes usually lasts longer than a dec-
ade [38–40], still could be that more immediate changes
may affect the associations. Finally, we did not set any a
priori effect threshold nor multiple comparisons
Fig. 3 Marginal effect plot of time–weighted average driving pressure on the probability of postoperative pulmonary complications by type of
surgery. Green: open surgery, Orange: closed surgery; solid lines are estimated marginal mean effect, and bandwidths are 95% confidence intervals
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correction; hence the results’ statistical significance and
the exploratory nature of secondary outcome analysis
must be confirmed in future trials.
Conclusions
ΔPTW is associated with the occurrence of PPCs and in-
traoperative adverse events in abdominal surgery. These
associations are present regardless of the type of surgical
approach and depend on the duration and actual ΔP.
Both in patients undergoing open or closed abdominal
surgery, the ΔP is a promising target for future strategies
to reduce PPCs.
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